Karol Zeleník1,2, Martin Formánek3,4, Radana Walderová3,4, Debora Formánková3,4, Pavel Komínek3,4. 1. Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. listopadu 1790, 70800, Ostrava, Czech Republic. karol.zelenik@fno.cz. 2. Department of Craniofacial Surgery, Faculty of Medicine, University of Ostrava, Syllabova 19, 70300, Ostrava, Czech Republic. karol.zelenik@fno.cz. 3. Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. listopadu 1790, 70800, Ostrava, Czech Republic. 4. Department of Craniofacial Surgery, Faculty of Medicine, University of Ostrava, Syllabova 19, 70300, Ostrava, Czech Republic.
Abstract
PURPOSE: To evaluate 5-year voice outcomes of vocal fold augmentation (VFA) using autologous fat (AF) injection via direct microlaryngoscopy versus office-based calcium hydroxylapatite (CaHA) injection. METHODS: Retrospective study of patients who underwent VFA between 2012 and 2015, with a 5-year follow-up. Patients with a glottic gap of ≤ 3 mm caused by unilateral vocal fold paralysis or vocal fold atrophy were included in the study. VFA was performed using AF injection via direct microlaryngoscopy in 17 patients, and using office-based CaHA injection in 19 patients. Subjective satisfaction with voice, voice handicap index (VHI), and maximal phonation time (MPT) were analyzed pre-injection, and at 12 and 60 months post-VFA. RESULTS: Altogether 36 patients underwent VFA between 2012 and 2015, of whom 5 were excluded within 1 year post-VFA, and 2 were excluded between 1 and 5 years post-VFA. Of the remaining 29 patients, 3 (10.3%) underwent re-intervention at between 1 and 3 years post-VFA. Thus, the 5-year follow-up included 26 patients (72.2%; 11 males and 15 females). At 5 years after surgery, 73.1% of the patients were satisfied with their voice, with no significant between-group difference (P = 0.307). The mean improvement of VHI was 28.8 ± 17.82 in the autologous fat group versus 33 ± 26.24 in the CaHA group (P = 0.458). MPT improvement was also similar between the two groups: 6.2 ± 4.26 for the autologous fat group versus 6.3 ± 4.34 for the CaHA group (P = 0.667). CONCLUSIONS: Both AF injection via direct microlaryngoscopy and office-based CaHA injection yielded good and comparable 5-year results.
PURPOSE: To evaluate 5-year voice outcomes of vocal fold augmentation (VFA) using autologous fat (AF) injection via direct microlaryngoscopy versus office-based calcium hydroxylapatite (CaHA) injection. METHODS: Retrospective study of patients who underwent VFA between 2012 and 2015, with a 5-year follow-up. Patients with a glottic gap of ≤ 3 mm caused by unilateral vocal fold paralysis or vocal fold atrophy were included in the study. VFA was performed using AF injection via direct microlaryngoscopy in 17 patients, and using office-based CaHA injection in 19 patients. Subjective satisfaction with voice, voice handicap index (VHI), and maximal phonation time (MPT) were analyzed pre-injection, and at 12 and 60 months post-VFA. RESULTS: Altogether 36 patients underwent VFA between 2012 and 2015, of whom 5 were excluded within 1 year post-VFA, and 2 were excluded between 1 and 5 years post-VFA. Of the remaining 29 patients, 3 (10.3%) underwent re-intervention at between 1 and 3 years post-VFA. Thus, the 5-year follow-up included 26 patients (72.2%; 11 males and 15 females). At 5 years after surgery, 73.1% of the patients were satisfied with their voice, with no significant between-group difference (P = 0.307). The mean improvement of VHI was 28.8 ± 17.82 in the autologous fat group versus 33 ± 26.24 in the CaHA group (P = 0.458). MPT improvement was also similar between the two groups: 6.2 ± 4.26 for the autologous fat group versus 6.3 ± 4.34 for the CaHA group (P = 0.667). CONCLUSIONS: Both AF injection via direct microlaryngoscopy and office-based CaHA injection yielded good and comparable 5-year results.
Authors: Giovanna Cantarella; Riccardo F Mazzola; Michele Gaffuri; Elisabetta Iofrida; Pietro Biondetti; Laura V Forzenigo; Lorenzo Pignataro; Sara Torretta Journal: Otolaryngol Head Neck Surg Date: 2017-11-21 Impact factor: 3.497
Authors: Lucian Sulica; Clark A Rosen; Gregory N Postma; Blake Simpson; Milan Amin; Mark Courey; Albert Merati Journal: Laryngoscope Date: 2010-02 Impact factor: 3.325
Authors: Timothy M McCulloch; Brian T Andrews; Henry T Hoffman; Scott M Graham; Michael P Karnell; Corey Minnick Journal: Laryngoscope Date: 2002-07 Impact factor: 3.325
Authors: Clark A Rosen; Jackie Gartner-Schmidt; Roy Casiano; Timothy D Anderson; Felicia Johnson; Marc Remacle; Robert T Sataloff; Jean Abitbol; Gary Shaw; Sanford Archer; Richard I Zraick Journal: Laryngoscope Date: 2009-05 Impact factor: 3.325